The clinical effects of high-intensity laser therapy on refractory wounds: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023157

Enrollment

Unknown

Registered

2019-05-14

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wounds

Interventions

control group:Conventional dressing change for wounds

HILT group:HILT treatment

LLLT group:LLLT treatment

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 30 to 65 years, male or female. 2.Open full-thickness wounds, such as postoperative wound dehiscence, poor healing wounds, diabetic foot ulcers, pressure sores and traumatic wounds, et al. 3.Agree and sign this informed consent for clinical research.

Exclusion criteria

Exclusion criteria: 1. Multiple system organ failure. 2. Systemic metabolic disease and systemic infectious diseases. 3. Severe cognitive impairment, language impairment, do not cooperate with the treatment. 4. Photodermatosis and systemic lupus erythematosus. 5. Severe hypertension(systolic blood pressure >180mmHg, diastolic blood pressure >120mmHg. 6. Coagulopathy or used anticoagulants recently. 7. Acutely malnourished. 8. Take immunosuppressive agents, hormones and other drugs affecting wound healing.

Design outcomes

Primary

Measure	Time frame
BWAT;PUSH;	—

Countries

China

Contacts

Public ContactShen Ying

The First Affiliated Hospital of Nanjing Medical University

6326007@qq.com+86 13913913930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026